N@N

Synergetics USA Announces Conference Call to Review Third Quarter of Fiscal Year 2011 Results

^{Published on 2011-05-23 04:45:32 - Market Wire}
 

Oa™FALLON, Mo.--([ BUSINESS WIRE ])--Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will host a conference call the morning of Wednesday, June 8, 2011, at 10:30 a.m. Eastern time to review the Companya™s results for the fiscal third quarter ended April 30, 2011. A newsrelease announcing the third quartera™s results will be issued on Tuesday, June 7, 2011, after market close.

During the call, David Hable, Synergeticsa™ President and Chief Executive Officer, and Pamela G. Boone, Executive Vice President and Chief Financial Officer, will provide an overview of the third quarter performance and business highlights.

The toll free dial-in number to participate live on this call is (800) 447-0521, confirmation code 29707308. For callers outside the U.S., the number is (847) 413-3238. The conference call will also be simulcast live at[ http://www.synergeticsusa.com ]. An online replay will be available on the Companya™s website for approximately 30 days.

About Synergetics USA, Inc.

Through continuous improvement and development of our people, our mission is to design, manufacture and market innovative microsurgical devices, capital equipment, accessories and disposables of the highest quality in order to assist and enable surgeons who perform microsurgery around the world to provide a better quality of life for their patients.

Synergetics USA, Inc. (aSynergetics USAa or the aCompanya) is a leading supplier of precision microsurgical devices. The Companya™s primary focus is on the microsurgical disciplines of ophthalmology and neurosurgery. Our distribution channels include a combination of direct and independent sales organizations and important strategic alliances with market leaders. The Companya™s product lines focus upon precision engineered, microsurgical, hand-held instruments and the delivery of various energy modalities for the performance of less invasive microsurgery including: (i) laser energy, (ii) ultrasonic energy, (iii) radio frequency energy for electrosurgery and lesion generation and (iv) visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. The Companya™s website address is [ http://www.synergeticsusa.com ].

Forward-Looking Statements

Some statements in this release may be aforward-looking statementsa for the purposes of the Private Securities Litigation Reform Act of 1995.In some cases forward-looking statements can be identified by words such as abelieve,a aexpect,a aanticipate,a aplan,a apotential,a acontinuea or similar expressions.Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.These factors, risks and uncertainties are discussed in Synergeticsa™ Annual Report on Form 10-K for the yearended July31, 2010, as updated from time to time in our filings with the Securities and Exchange Commission.